STARD3NL as a prognostic marker related to an immunosuppressive tumor microenvironment in hepatocellular carcinoma
It is indicated that STARD3NL may have value as a prognostic biomarker associated with an immunosuppressive tumor microenvironment and patients with increased STARD3NL expression had poorer survival and multivariable analysis supported STARD3NL as an independent risk factor.